Answers are grounded in this paper and cite their sources.
Objective: To analyze the results of maternal serological prenatal screening in the middle trimester. Methods: The study was conducted on 7815 middle-pregnant women who underwent prenatal screening in our hospital between January 2021 and December 2022, of which pregnant women aged 35 years and above were taken as the high-age group; those who were under 35 years old were included in the low-age group. The results of maternal serological screening in mid-pregnancy were analyzed. Results: The probability of detecting the disease was higher in prenatal screening results. Conclusion: Maternal serologic prenatal screening in the middle trimester has the advantages of economy and convenience, and can effectively reduce birth defects in newborns, which is of some value for promotion.
No takes yet. Share an insight, caveat, or question.
Lv et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: